CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. SION
2. CSQR
3. SPY
4. B
5. TTWO
6. NVDA
7. STDN
8. MNDY
9. ACH
10. RHP

Go back to CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
(NASDAQ: CRVO) Delayed: 2.83 -0.04 (1.39%)
Previous Close $2.87    52 Week High $ 
Open $2.87    52 Week Low $ 
Day High $2.88    P/E N/A 
Day Low $2.66    EPS $ 
Volume 254,752